Opioid Induced Constipation Market Share, Size, Trends, Industry Analysis Report, By Active Ingredients; By Prescription Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024

Description

List of Tables

The global opioid induced constipation market size is expected to reach USD 3.93 billion by 2032, according to a new study by Polaris Market Research. The report "Opioid Induced Constipation Market Share, Size, Trends, Industry Analysis Report, By Active Ingredients; By Prescription Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Opioids are most used to get relief from pain, as they include morphine, tramadol, and fentanyl. The increased accessibility of painkillers at retail and online e-commerce platforms is showing a positive impact on the demand for opioids in the marketplace, including significant growth potential for opioid-induced constipation.

The rising awareness campaigns by pharmaceutical companies, governments, and non-government agencies are demonstrating a positive impact on the opioid-induced constipation market. For instance, in 2023, Salix Pharmaceuticals, a drug manufacturer, along with the other two non-profit organisations, declared December 5 as the opioid-induced constipation awareness day to confront the stigmas surrounding the issue.

The rising use of opioids among the larger consumer base is expected to boost demand for opioid-induced constipation treatment. According to the available data, among the individuals who consumed opioids without cancer, around 40-60% of the people get opioid-induced constipation (OIC).

The higher risk of constipation with the intake of opioid-related drugs, along with the growing research studies to review the potential causes and suitable treatments, are showing wider growth opportunities for the market. For instance, a study published in the National Library of Medicine explored opioid-induced constipation and reviewed potential therapeutic and non-therapeutic treatments to treat the disease.

Furthermore, the use of opioids can be related to the rising use by cancer patients to get pain relief. According to pharmaceutical experts, approximately 60 to 90% of patients who took the opioid for cancer treatment suffered from opioid-induced constipation. Opioid-induced constipation patients are likely to face more difficulties in day-to-day life activities, primarily those facing cancer pain.

Moreover, research activities are positively influencing the creation of effective treatments for patients suffering from opioid-induced constipation. For instance, a 2024 study focused on finding the relationship between opioid-induced constipation and the P2Y1 receptor in the colonic myenteric plexus of rats.

Opioid Induced Constipation Market Report Highlights

Naloxegol segment will grow at the fastest pace, due to its potential for treating opioid induced constipation issues.

Prescription segment held the largest share, owing to the rising importance of doctor consultation.

Oral segment dominated the market, primarily due to its ease of treatment intake and higher effectiveness.

Asia Pacific will register the fastest pace, attributable to the presence of the large proportion of elderly population.

The global players include Abbott, Aurobindo Pharma, Bayer, Boehringer Ingelheim International, & Bristol Myers Squibb Company.

Polaris Market Research has segmented the opioid induced constipation market report based on active ingredients, prescription type, route of administration, distribution channel and region:

Opioid Induced Constipation, Active Ingredients Outlook (Revenue - USD Billion, 2019 - 2032)

Naloxegol
Lubiprostone
Methylnaltrexone Bromide
Docusate Sodium
Others

Opioid Induced Constipation, Prescription Type Outlook (Revenue - USD Billion, 2019 - 2032)

Over The Counter Medicines
Prescription, Natural Remedies

Opioid Induced Constipation, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Oral
Injectable
Others

Opioid Induced Constipation, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Opioid Induced Constipation, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Product Code: PM4344

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Opioid Induced Constipation Market Insights

4.1. Opioid Induced Constipation - Industry Snapshot
4.2. Opioid Induced Constipation Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. The presence of an elderly population
  - 4.2.1.2. The significant rise in opioid prescriptions
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. The declining use of opioids in the marketplace
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Opioid Induced Constipation Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Opioid Induced Constipation Market, by Active Ingredients

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
5.3. Naloxegol
- 5.3.1. Global Opioid Induced Constipation Market, by Naloxegol, by Region, 2019-2032 (USD Billion)
5.4. Lubiprostone
- 5.4.1. Global Opioid Induced Constipation Market, by Lubiprostone, by Region, 2019-2032 (USD Billion)
5.5. Methylnaltrexone Bromide
- 5.5.1. Global Opioid Induced Constipation Market, by Methylnaltrexone Bromide, by Region, 2019-2032 (USD Billion)
5.6. Docusate Sodium
- 5.6.1. Global Opioid Induced Constipation Market, by Docusate Sodium, by Region, 2019-2032 (USD Billion)
5.7. Others
- 5.7.1. Global Opioid Induced Constipation Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Opioid Induced Constipation Market, by Prescription Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
6.3. Over The Counter Medicines
- 6.3.1. Global Opioid Induced Constipation Market, by Over The Counter Medicines, by Region, 2019-2032 (USD Billion)
6.4. Prescription, Natural Remedies
- 6.4.1. Global Opioid Induced Constipation Market, by Prescription, Natural Remedies, by Region, 2019-2032 (USD Billion)

7. Global Opioid Induced Constipation Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
7.3. Oral
- 7.3.1. Global Opioid Induced Constipation Market, by Oral, by Region, 2019-2032 (USD Billion)
7.4. Parenteral
- 7.4.1. Global Opioid Induced Constipation Market, by Parenteral, by Region, 2019-2032 (USD Billion)
7.5. Others
- 7.5.1. Global Opioid Induced Constipation Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Opioid Induced Constipation Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
8.3. Hospital Pharmacy
- 8.3.1. Global Opioid Induced Constipation Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
8.4. Online Pharmacy
- 8.4.1. Global Opioid Induced Constipation Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)
8.5. Retail Pharmacy
- 8.5.1. Global Opioid Induced Constipation Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)

9. Global Opioid Induced Constipation Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Opioid Induced Constipation Market Assessment, By Geography, 2019-2032 (USD Billion)
9.3. Opioid Induced Constipation Market - North America
- 9.3.1. North America: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
- 9.3.2. North America: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.3.3. North America: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
- 9.3.4. North America: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.5. Opioid Induced Constipation Market - U.S.
  - 9.3.5.1. U.S.: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.3.5.2. U.S.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.3.5.3. U.S.: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.3.5.4. U.S.: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.3.6. Opioid Induced Constipation Market - Canada
  - 9.3.6.1. Canada: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.3.6.2. Canada: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.3.6.3. Canada: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.3.6.4. Canada: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
9.4. Opioid Induced Constipation Market - Europe
- 9.4.1. Europe: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
- 9.4.2. Europe: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.4.3. Europe: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
- 9.4.4. Europe: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.5. Opioid Induced Constipation Market - UK
  - 9.4.5.1. UK: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.5.2. UK: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.5.3. UK: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.5.4. UK: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.6. Opioid Induced Constipation Market - France
  - 9.4.6.1. France: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.6.2. France: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.6.3. France: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.6.4. France: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.7. Opioid Induced Constipation Market - Germany
  - 9.4.7.1. Germany: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.7.2. Germany: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.7.3. Germany: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.7.4. Germany: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.8. Opioid Induced Constipation Market - Italy
  - 9.4.8.1. Italy: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.8.2. Italy: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.8.3. Italy: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.8.4. Italy: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.9. Opioid Induced Constipation Market - Spain
  - 9.4.9.1. Spain: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.9.2. Spain: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.9.3. Spain: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.9.4. Spain: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.10. Opioid Induced Constipation Market - Netherlands
  - 9.4.10.1. Netherlands: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.10.2. Netherlands: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.10.3. Netherlands: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.10.4. Netherlands: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.4.11. Opioid Induced Constipation Market - Russia
  - 9.4.11.1. Russia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.4.11.2. Russia.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.4.11.3. Russia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.4.11.4. Russia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
9.5. Opioid Induced Constipation Market - Asia Pacific
- 9.5.1. Asia Pacific: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
- 9.5.2. Asia Pacific: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.5.3. Asia Pacific: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
- 9.5.4. Asia Pacific: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.5. Opioid Induced Constipation Market - China
  - 9.5.5.1. China: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.5.2. China.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.5.3. China: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.5.4. China: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.6. Opioid Induced Constipation Market - India
  - 9.5.6.1. India: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.6.2. India.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.6.3. India: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.6.4. India: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.7. Opioid Induced Constipation Market - Japan
  - 9.5.7.1. Japan: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.7.2. Japan.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.7.3. Japan: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.7.4. Japan: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.8. Opioid Induced Constipation Market - Malaysia
  - 9.5.8.1. Malaysia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.8.2. Malaysia.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.8.3. Malaysia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.8.4. Malaysia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.9. Opioid Induced Constipation Market - Indonesia
  - 9.5.9.1. Indonesia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.9.2. Indonesia.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.9.3. Indonesia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.9.4. Indonesia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.5.10. Opioid Induced Constipation Market - South Korea
  - 9.5.10.1. South Korea: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.5.10.2. South Korea.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.5.10.3. South Korea: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.5.10.4. South Korea: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
9.6. Opioid Induced Constipation Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
- 9.6.2. Middle East & Africa: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.6.3. Middle East & Africa: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
- 9.6.4. Middle East & Africa: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.5. Opioid Induced Constipation Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.6. Opioid Induced Constipation Market - South Africa
  - 9.6.6.1. South Africa: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.6.6.2. South Africa: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.6.6.3. South Africa: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.6.6.4. South Africa: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.7. Opioid Induced Constipation Market - Israel
  - 9.6.7.1. Israel: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.6.7.2. Israel: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.6.7.3. Israel: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.6.7.4. Israel: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.6.8. Opioid Induced Constipation Market - UAE
  - 9.6.8.1. UAE: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.6.8.2. UAE: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.6.8.3. UAE: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.6.8.4. UAE: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
9.7. Opioid Induced Constipation Market - Latin America
- 9.7.1. Latin America: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
- 9.7.2. Latin America: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
- 9.7.3. Latin America: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
- 9.7.4. Latin America: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.5. Opioid Induced Constipation Market - Mexico
  - 9.7.5.1. Mexico: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.7.5.2. Mexico: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.7.5.3. Mexico: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.7.5.4. Mexico: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.6. Opioid Induced Constipation Market - Brazil
  - 9.7.6.1. Brazil: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.7.6.2. Brazil: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.7.6.3. Brazil: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.7.6.4. Brazil: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
- 9.7.7. Opioid Induced Constipation Market - Argentina
  - 9.7.7.1. Argentina: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
  - 9.7.7.2. Argentina: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
  - 9.7.7.3. Argentina: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
  - 9.7.7.4. Argentina: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott (US)
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Aurobindo Pharma (India)
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bayer AG (Germany)
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Boehringer Ingelheim International GmbH. (Germany)
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Bristol Myers Squibb Company (US)
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Cosmo Pharmaceuticals (Ireland)
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Daewoong Pharmaceutical Company (South Korea)
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. F. Hoffmann-La Roche Ltd (Switzerland)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Fresenius Kabi AG (Germany)
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. GSK Plc. (UK)
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Hikma Pharmaceuticals PLC (UK)
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Merck & Co Inc. (US)
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Mylan NV (US)
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Novartis AG (Switzerland)
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Pfizer Inc (US)
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development

Product Code: PM4344

List of Tables

Table 1 Global Opioid Induced Constipation Market, by Active Ingredients, by Region, 2019-2032 (USD Billion)
Table 2 Global Opioid Induced Constipation Market, by Prescription Type, by Region, 2019-2032 (USD Billion)
Table 3 Global Opioid Induced Constipation Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
Table 4 Global Opioid Induced Constipation Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
Table 5 Opioid Induced Constipation Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 6 North America: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 7 North America: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 8 North America: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 9 North America: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 10 U.S.: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 11 U.S.: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 12 U.S.: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 13 U.S.: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 14 Canada: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 15 Canada: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 16 Canada: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 17 Canada: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 18 Europe: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 19 Europe: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 20 Europe: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 21 Europe: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 22 Germany: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 23 Germany: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 24 Germany: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 25 Germany: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 26 France: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 27 France: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 28 France: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 29 France: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 30 UK: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 31 UK: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 32 UK: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 33 UK: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 34 Italy: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 35 Italy: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 36 Italy: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 37 Italy: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 38 Netherlands: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 39 Netherlands: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 40 Netherlands: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 41 Netherlands: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 42 Spain: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 43 Spain: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 44 Spain: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 45 Spain: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 46 Russia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 47 Russia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 48 Russia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 49 Russia: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 50 Asia Pacific: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 51 Asia Pacific: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 52 Asia Pacific: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 53 Asia Pacific: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 54 China: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 55 China: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 56 China: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 57 China: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 58 Japan: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 59 Japan: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 60 Japan: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 61 Japan: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 62 India: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 63 India: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 64 India: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 65 India: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 66 Indonesia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 67 Indonesia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 68 Indonesia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 69 Indonesia: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 70 Malaysia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 71 Malaysia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 72 Malaysia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 73 Malaysia: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 74 South Korea: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 75 South Korea: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 76 South Korea: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 77 South Korea: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 78 Latin America: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 79 Latin America: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 80 Latin America: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 81 Latin America: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 82 Brazil: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 83 Brazil: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 84 Brazil: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 85 Brazil: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 86 Mexico: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 87 Mexico: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 88 Mexico: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 89 Mexico: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 90 Argentina: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 91 Argentina: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 92 Argentina: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 93 Argentina: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 94 Middle East & Africa: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 95 Middle East & Africa: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 96 Middle East & Africa: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 97 Middle East & Africa: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 98 UAE: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 99 UAE: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 100 UAE: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 101 UAE: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 102 Saudi Arabia: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 103 Saudi Arabia: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 104 Saudi Arabia: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 105 Saudi Arabia: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 106 South Africa: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 107 South Africa: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 108 South Africa: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 109 South Africa: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)
Table 110 Israel: Opioid Induced Constipation Market, by Active Ingredients, 2019-2032 (USD Billion)
Table 111 Israel: Opioid Induced Constipation Market, by Prescription Type, 2019-2032 (USD Billion)
Table 112 Israel: Opioid Induced Constipation Market, by Route of Administration, 2019-2032 (USD Billion)
Table 113 Israel: Opioid Induced Constipation Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Opioid Induced Constipation Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Active Ingredients
Figure 7. Global Opioid Induced Constipation Market, by Active Ingredients, 2021 & 2030 (USD Billion)
Figure 8. Market by Distribution Channel
Figure 9. Global Opioid Induced Constipation Market, by Distribution Channel, 2021 & 2030 (USD Billion)
Figure 10. Market by Prescription Type
Figure 11. Global Opioid Induced Constipation Market, by Prescription Type, 2021 & 2030 (USD Billion)
Figure 12. Market by Route of Administration
Figure 13. Global Opioid Induced Constipation Market, by Route of Administration, 2021 & 2030 (USD Billion)

Opioid Induced Constipation Market Share, Size, Trends, Industry Analysis Report, By Active Ingredients; By Prescription Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

Description

Table of Contents

List of Tables

Opioid Induced Constipation Market Report Highlights

Opioid Induced Constipation, Active Ingredients Outlook (Revenue - USD Billion, 2019 - 2032)

Opioid Induced Constipation, Prescription Type Outlook (Revenue - USD Billion, 2019 - 2032)

Opioid Induced Constipation, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Opioid Induced Constipation, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Opioid Induced Constipation, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Opioid Induced Constipation Market Insights

5. Global Opioid Induced Constipation Market, by Active Ingredients

6. Global Opioid Induced Constipation Market, by Prescription Type

7. Global Opioid Induced Constipation Market, by Route of Administration

8. Global Opioid Induced Constipation Market, by Distribution Channel

9. Global Opioid Induced Constipation Market, by Geography

10. Competitive Landscape

11. Company Profiles

List of Tables

List of Figures